At Emerald Development Managers, we not only provide long-term investment capital, we also guide our early-stage companies along a strategic path to profitability, increased market share, and sustained growth. Here's how some of our current portfolio companies are doing.
As the hydrogen economy continues to evolve, innovative technologies are emerging to make hydrogen production more efficient and cost-effective. One company at the forefront of this innovation is ETCH, co-founded by Dr Jonah Erlebacher.
Digital pathology developer Proscia is launching an artificial intelligence toolkit for life science researchers alongside a program that translates biopsy slide images into quantitative data for easier number-crunching by AI models.
BetterWay, launched by Austin start-up Babson Diagnostics, aims to deliver a service that the Silicon Valley con artists at Theranos only promised.
Theranos’s ambitions for a finger-prick blood test are finally being realized—by other companies. Since May, needle-phobic people in Austin, Texas, have been able to visit pharmacies for routine medical tests on drops of blood squeezed from their fingertips, rather than the usual way of plunging a needle into a vein in the arm and drawing large vials of blood.
The company’s Concentriq AP Dx software allows pathologists to make a primary diagnosis from an image on their computer screen, rather than a glass slide.
WATT Fuel Cell today announced the expansion of its U.S. Advanced Manufacturing Plant and Headquarters facility in Mt. Pleasant, Pennsylvania. This expansion bolsters WATT’s manufacturing capabilities for scaled commercial production of the company’s newest distributed energy, small-scale fuel cell products, WATT HOME, WATT REMOTE and WATT NOMAD.
Babson Diagnostics, a science-first health technology company, announced today that it will launch BetterWay™ blood testing with three retail partners in Austin and San Antonio. BetterWay brings blood testing into the 21st century, making it less invasive, more convenient, and accessible for consumers. Babson is launching BetterWay with H-E-B, one of the nation’s largest independently owned supermarket chains, and two independent pharmacies in the Austin metro area, Peoples Rx and Lake Hills Pharmacy. BetterWay will be available at select pharmacy locations in the Austin and San Antonio metro areas beginning in July.
Strategic alliance allows Prime to offer exclusive access to Capital Rx's leading technology platform to achieve a higher standard of care, increase efficiency, improve experiences and provide the foundation for the next generation of integrated pharmacy care for the more than 50 million Americans served by Prime.
Sustainable biotechnology company Evolved by Nature has partnered with leading life science company Barentz to distribute the first ingredient from their platform of natural, bioactive peptides to be made available to the personal care and beauty markets. Distribution will be throughout the US and Canada.
"The best path forward for the clean energy transition has long divided opinion, but the extremes in the reactions to the White House’s recent hydrogen production tax credit proposal – ranging from a “much-needed win” to “horrible” – show just how deep those divisions go." - Jonah Erlebacher, Founder - ETCH
Philadelphia-based software firm, Proscia, has received FDA 510(k) clearance for its Concentriq AP-Dx pathology system for its diagnostic software that it says provides a better more immersive setting for clinicians than other systems of pathology.
Babson Diagnostics™, a science-first, health care technology company, today announced that a key piece of its BetterWay™ Blood Testing ecosystem has achieved 510(k) clearance from the U.S. Food and Drug Administration. These regulatory clearances pave the way for Babson to bring BetterWay—a first-of-its-kind blood testing service—to market next year.
Theranos had a lot of bad ideas, but making blood draws smaller and easier wasn’t necessarily one of them. A decade after the now-defunct blood-testing startup emerged from stealth, BD has now claimed an FDA clearance for fingerstick collection hardware that aims to bring the most common blood tests to pharmacies, grocery stores and other retail locations. The green light marks a major milestone in the blood collection giant’s long-running collaboration with Babson Diagnostics, the Fierce Medtech Fierce 15 winner that’s been co-developing an effective capillary blood draw system with BD since 2016.
All of a sudden, there's a flurry of activity in developing treatments for PTSD—meaning companies have to bring compelling data. Transcend Therapeutics is hoping to rise above the competition with an early cut of phase 2 data showing its MDMA analog reduced the severity of the condition in patients.
Evolved By Nature has 14 top tanneries supporting its eco-friendly substitute for chemical-heavy leather finishings. It’s a major advancement since the sustainable chemistry company raised $120 million last year.
In mid-October, Senator Joe Manchin announced that the Appalachian Regional Clean Hydrogen Hub (ARCH2) was selected to negotiate for funding by the U.S. Department of Energy (DOE) to receive up to $925 million in federal support. Hope Gas (Hope) is excited to be a project partner and support the ARCH2 vision of a clean, economically viable and socially equitable H2 ecosystem. As part of this project, Hope will work with WATT Fuel Cell (WATT) to provide fuel cells to residential customers in West Virginia.
Capital Rx, the full-service pharmacy benefit manager (PBM) and pharmacy benefit administrator (PBA) advancing our nation's healthcare infrastructure to improve drug price visibility and patient outcomes, is announcing the closing of a strategic investment round totaling over $50 million with participation from more than 10 of the leading health systems in the nation.
Baltimore startup Etch closed a $7.5 million seed round to build what it says are efficient systems to decarbonize natural gas, the company tells Axios.
Cyware, a startup developing products to help enterprises modernize their security operations, today announced that it raised $30 million in a Series C funding round led by Ten Eleven Ventures. Advent International, Zscaler, Emerald Development Managers, Prelude and Great Road Holdings also participated, bringing Cyware’s total raised to $73 million.
Socure, a Nevada-based startup that provides digital identity verification and fraud prevention solutions, has announced its first acquisition: Berbix, a San Francisco-based startup that developed a high-accuracy document verification solution. The deal, valued at approximately $70 million in cash and stock, marks a significant milestone for Socure as it aims to become the leader in the identity verification market.
Torigen Pharmaceuticals Inc. – which is in the process of developing new cancer vaccine products for pets – has settled into a new 9,090-square-foot headquarters space in Farmington as it continues its growth trajectory.
GOLF.com details how one country club is utilizing GreenSight's technology to improve irrigation, lower water costs, and yield purer playing conditions.
Agilent Technologies Inc. (NYSE: A) today announced a multi-year distribution agreement with Proscia® – a leader in digital pathology – to offer a comprehensive digital diagnostic pathology system.
HPE intends to acquire Axis Security, a cloud security provider, expanding its edge-to-cloud security capabilities by offering a unified Secure Access Services Edge (SASE) solution to meet the increasing demand for integrated networking and security solutions delivered as-a-service.
Transcend Therapeutics Inc. raised $40 million from venture-capital investors in January to develop a post-traumatic stress disorder treatment that its 29-year-old CEO Blake Mandell says would require about half the amount of therapy as MDMA, or ecstasy, a popular hallucinogen.
WATT Fuel Cell is excited to announce an investment from Generac Power Systems, a market leader in residential energy technology.
Emerald Development Managers, an early-stage venture capital firm, today announced that Ian Tolfree, Ph.D., and Cy Schroeder have been named Principals of the firm and Joshua Smith has been promoted to Director, Investor Relations.
Capital Rx, a healthcare technology company changing the way prescription drugs are priced and patients are serviced, today announced that it has won the Fierce Healthcare Fierce Innovation Award. The healthcare awards program recognized Capital Rx for JUDI®, its ground-breaking enterprise health platform (EHP) for pharmacy benefit administration.
Torigen Pharmaceuticals, Inc, a commercial-stage animal health biologics company, today announced it has closed its $13 million Series A1 round led by Werth Family Investment Associates, LLC and Connecticut Innovations, Inc., bringing the total raised by the company to $18 million.
GreenSight’s WeaterHive, a unique new sensing technology that uses swarms of nano-sized drones to directly measure atmospheric conditions, has been selected by the US Air Force and the Defense Innovation Unit for a prototype development contract and potential procurement.
LifeSprout, a privately held regenerative medicine company founded with technology licensed from Johns Hopkins University, today announced positive six-month interim results from its pivotal clinical trial of Lumina™, a revolutionary dermal filler.
Proscia, a leading provider of digital and computational pathology solutions, has introduced the next version of its Concentriq® Dx platform for primary diagnostic workflows. The release brings together new features and a compelling user experience to help even the largest laboratory networks transition to 100% digital diagnosis.
Evolved by Nature has raised $120 million in Series C financing in a round led by Teachers’ Venture Growth, part of the Ontario Teachers’ Pension Plan Board, and Senator Investment Group, with participation from existing investors including Mousse Partners, Jeff Vinik, The Kraft Group, Roy Disney, Emerald Development Managers and Chanel.
With $37 million in new funding, Philadelphia-based Proscia is using computational pathology to advance the ways in which cancer is understood and treated.
Torigen Pharmaceuticals, Inc, a commercial-stage animal health biologics company, announced today that it has entered into a national distribution agreement with MWI Animal Health, a leading distributor of animal health products and services and a subsidiary of AmerisourceBergen. The agreement will expand access to Torigen’s experimental autologous cancer vaccine for companion animals.
Emerald Development Managers today announced that Abbe Serphos has been appointed Operating Partner and Head of Communications for the firm.
On Monday, New York-based Capital Rx announced it has raised $106 million in Series C funding led by B Capital Group, which brings the company’s total funding to $175 million since launching in 2017. General Catalyst, Transformation Capital and Edison Partners also participated in the round. The company declined to disclose its post-money valuation.
WATT Fuel Cell Corp ("WATT") announced their new 1500W Imperiumᴿ Solid Oxide Fuel Cell System received ETL certification to operate on either natural gas or liquid propane gas. The system's ETL certification complies to North American safety standards.
Last year, U.K. cybersecurity startup CybSafe, a “behavioral security” platform, raised a $7.9 million Series A. It’s now raised a $28 million Series B round led by Evolution Equity Partners with participation from Emerald Development Managers and existing investors IQ Capital and Hannover Digital Investments (HDI) GmbH.
WATT Fuel Cell ("WATT") announced a technological advancement that dramatically increases the efficiency of its fuel cells and reduces their already minimal CO2 emissions.
BD is expanding its long-running partnership with the blood collection company Babson Diagnostics, which aims to make taking a high-quality sample in pharmacies, grocery stores or at home as easy as possible.
Today, Intellihot, the leading clean technology manufacturer creating sustainable solutions for the built environment, announced its partnership with the iconic Loews Miami Beach Hotel to upgrade the hotel’s hot water systems. The innovative iQ1505 Intellihot replaced the previous legacy system of three large boilers and 1,200 gallons of stored water, which will reduce energy waste and the hotel’s carbon footprint while improving cost effectiveness.
Largest consultant led pharmacy coalition in the U.S. taps Capital Rx to offer clients flexibility, transparency, and competitive drug pricing.
Proscia®, the leader in digital and computational pathology solutions, today announced a multi-year OEM agreement with Siemens Healthineers. Under the agreement, Siemens Healthineers will expand its Enterprise Imaging offering towards the global digital pathology market using Proscia’s Concentriq® Dx platform.
WATT Fuel Cell announced today that it has closed a financing round led by EQT Corporation, the largest natural gas producer in the United States, to continue the company's development and commercialization of its solid oxide fuel cell technology.
Intellihot — a leading greentech manufacturer working to improve the sustainability of commercial buildings — released its 2022 Environmental Report outlining how its products have already reduced carbon expenditures in the built environment by 6.6 billion pounds.
Capital Rx has been chosen as one of Fierce Healthcare's 2022 "Fierce 15", a selection of the most promising healthcare companies in the industry.
Evolved By Nature, the company behind Activated Silk, has raised $70 million in funding with backers including Mousse Partners. A new production facility is to come.
Founded in 2009, Intellihot has been on a mission to make commercial buildings more efficient, by improving the cost and physical footprint of keeping building H2O nice and toasty. The company just announced it raised $50 million to shake up the $81 billion global HVAC market, with plans to expand internationally. The round was led by investors Aegon Asset Management and the Avenue Sustainable Solutions Fund.
Capital Rx, a healthtech company changing the way prescription drugs are priced and patients are serviced, was recently recognized by The Startup Weekly as a recipient of the 2021 Customer Choice Award.
SafeBreach, the pioneer in breach and attack simulation ("BAS"), today announced that it has raised $53.5 million in Series D funding, led by Sonae IM and Israel Growth Partners (IGP), with additional participation from Sands Capital and Leumi Partners.
Socure, a company that uses AI and machine learning to verify identities, announced today that it raised $450 million in funding for its Series E round led by Accel and T. Rowe Price. The round brings the company’s valuation to $4.5 billion, up from $1.3 billion this March when it raised $100 million for its Series D.
Melanoma is the deadliest form of skin cancer and can be challenging to diagnose. Earlier this month, Proscia released study data in which artificial intelligence (AI) was used to detect melanoma with a high degree of accuracy.
Proscia has released study results on new technology that leverages artificial intelligence (AI) to automatically detect melanoma, the deadliest form of skin cancer, with a high degree of accuracy.
Cyware, the industry's only Virtual Cyber Fusion platform provider, today announced that it has been named the winner of the Overall SOAR Solution Provider of the Year award in the fifth annual CyberSecurity Breakthrough Awards program conducted by CyberSecurity Breakthrough.
Cyware, the industry’s only Virtual Cyber Fusion platform provider, today announced new threat intelligence sharing abilities for industry ISACs and ISAOs and their member organizations. The capabilities are driven by Cyware’s Virtual Cyber Fusion platform and its supporting solutions that empower organizations to achieve the end-to-end threat sharing needed for collective defense.
TrueFort announces $30M Series B with participation from new firms Canaan and Ericsson Ventures along with existing investors Evolution Equity Partners, Lytical Ventures, and Emerald Development Managers.
Capital Rx announced Wednesday that it now has a consumer prescription card, Capital Rx Advantage. This card can be obtained by anyone to buy medication at a price the company says is lower 80% of the time compared to its competitors.
In the past two months, Torigen has won multiple awards at several prominent industry events including the Yale Innovation Summit and the Animal Health Innovation Showcase.
Emerald Development Managers LP leads oversubscribed $31 million Series B funding round for Babson Diagnostics with full participation from existing investors, including Siemens Healthineers.
The National Bank of Bahrain Group (NBB Group) has selected Cyware to power the first Virtual Cyber Fusion Centre (vCFC) in the region.
Proscia has introduced the next generation of its flagship Concentriq® platform to help the world’s largest laboratory networks keep pace with the growing need for diagnostic services in the post-COVID era.
Results demonstrate company’s commitment to client service, outpacing competitors.
The funding is being co-led by Advent International and Ten Eleven Ventures.
Socure — which uses AI and machine learning to verify identities — announced Tuesday that it has raised $100 million in a Series D funding round at a $1.3 billion valuation.
Due for repairs, the Grand Hyatt Vail turns to Intellihot for tankless water heating reliability, cost savings, and cutting OPEX.
The partnership assures the enhancement of secure operations and collaborative threat response in defending the space industry from both traditional and evolving cybersecurity threats.
Security Industry Luminary Brings Decades of Strategic Management and Operational Experience to New Board Seat
The funding round is led by Transformation Capital, with participation from Edison Partners, who led Capital Rx’s Series A financing in 2019, and Emerald Development Managers, LP.
Annual The Software Report List Recognizes Vendors that Provide the Most Innovative and Technically Advanced Approaches for Protecting Customers
Provider of Application and Cloud Workload Protection Cited for Innovation, Relevance and Market Adoption
Investment to accelerate adoption of digital pathology, transforming the 150-year-old standard of care for cancer diagnosis.
The multi-phase project will digitize the world’s largest human pathology specimen repository in order to enhance biomedical research for cancer and infectious diseases.